Change Country
Welcome to LuxembourgWelcome
Please read the important information below before continuing to our website

The Lyxor ETFs on this website may be restricted for certain individuals or in certain countries pursuant to the national regulations applicable to those individuals or countries. It is therefore your responsibility to ensure that you are authorised to invest in the Lyxor ETFs on this website. 


If you are an investor in the United Kingdom, please go to  

If you are an investor in the Netherlands, please go to  

If you are an investor in Italy, please go to  

If you are an investor in Spain, please go to  

If you are an investor in Austria, please go to  

If you are an investor in Germany, please go to   

If you are an investor in Singapore, please go to  

If you are an investor in Switzerland, please go to  

If you are an investor in Belgium, please go to  

If you are an investor in Poland, please go to 

If you are an investor in Norway, please go to

If you are an investor in Denmark, please go to

If you are an investor in Luxembourg, please go to

If you are an investor in Sweden, please go to

If you are an investor in Finland, please go to



The Lyxor ETFs on this website are undertakings for collective investment in transferable securities (UCITS) (i) domiciled in France and approved by the Autorité des Marchés Financiers (AMF) or, (ii) domiciled in Luxembourg, approved by the Commission de Surveillance du Secteur Financier (CSSF) and authorised to market their units or shares in the French Republic in accordance with the notification procedure under Article 93 of Directive 2009/65/EC. Investors should note that the prospectuses of certain Lyxor ETFs under Luxembourg law that have been notified in accordance with this procedure are only available on the website in English. A French translation of these prospectuses can be obtained upon request by sending a letter to Lyxor International Asset Management (“Lyxor”) – 17 Cours Valmy, 92987 Paris La Défense, France.


The information on this website is not intended for persons or entities that are resident, located or registered in jurisdictions that are not authorised to distribute Lyxor ETFs. As a result, the information on this website does not constitute an offer or solicitation to buy or sell units or shares in these ETFs by anyone in any jurisdiction:


(a)   in which such an offer or solicitation is unauthorised;

(b)   in which Lyxor is not qualified to make such an offer or solicitation; or 

(c)   in which it is unlawful to make such an offer or solicitation.


In particular, the Lyxor ETFs on this website are not and will not be registered under the United States Securities Act of 1933, as amended. As such, they may not be offered or sold within the United States of America, except in specific cases where transactions are exempt from registration under the Securities Act. The ETFs listed on this website may not be sold to US citizens or transferred to the United States by any other means, unless this transaction is not subject to any specific registration under US law. 


Any person from a jurisdiction to which the above-mentioned restrictions apply should inform themselves of and observe these restrictions.


This website is intended for commercial purposes and is not regulatory in nature. Although the information provided has been drawn up on the basis of sources considered to be reliable, there is no guarantee that it is accurate, complete or relevant. Some of the information on this website is provided on the basis of market data collected at a specific time and may therefore vary over time. Lyxor advises investors to read the risk factors section of the prospectus and the key investor information document carefully. These documents can be found on the website.


The net asset value (“NAV”) of Lyxor ETFs may at any time be subject to considerable price fluctuations, which in some cases may lead to the loss of all of the capital invested. Investors should note that some ETFs may be sensitive to fluctuations in the exchange rate between their reference currency and that of the underlying index, as well as of the components of the underlying index.


Before investing in a Lyxor ETF, you should carry out your own risk analysis of the product from a legal, tax and accounting perspective, rather than basing your decision solely on the information provided. If necessary, you should consult your own advisers or any other qualified professional. 


Subject to compliance with the legal obligations by which they are bound, Lyxor or any entity within the same group shall not be held liable for any financial or other consequences of an investment in the product. 



By clicking on institutional or individual above, I confirm that I have read and understood the information provided herein, and that I am resident or registered in Luxembourg.


17 Aug 2017

Q3 2017 Outlook: Should you believe in fairytales?


Once upon a time in the West...  

So, where to begin? Macron’s march, May’s misery, Corbyn’s calamitous maths or Trump’s travails? Nothing is certain it seems in politics these days. Yet continued central bank support means bond and equity markets alike have largely taken it in their stride. Can the fairytale continue?


Hidden by headlines

About the only thing that isn’t overheating in the US right now is the economy. Sub-2.5% GDP growth allows the Fed to tighten “only” moderately, which is a burden for the dollar and a trigger for risk-taking elsewhere. And it comes at a time when economic growth in the euro area and Japan is accelerating and China’s policies remain supportive ahead of a potential leadership reshuffle at the all-important 19th Party Congress in the autumn. It all points to equities over bonds. 

The expected pre-summer acceleration of the US economy should also boost commodity prices. Closer to home, some Brexit pain is all but guaranteed. Consumer confidence could be dented and UK assets, especially sterling, could come under renewed pressure.


O ye of little faith

Some of the optimism over Trump’s spending plans has evaporated, rather like the detail, as overly positive soft data finally became decent hard data. Despite his seemingly daily struggles with Congress, we expect parts of his economic agenda to make it through, notably proposed tax cuts for individuals and businesses. Tax cuts are vote winners, so looming 2018 mid-terms will force the issue. There are other “wins” on the horizon as well, including the Treasury’s bold bank de-regulation plan, and revised health care legislation.  

Whether long-term success is likely is another question. Trump’s turbulent apprenticeship on the Hill is a strong incentive to diversify into regions where structural reforms have been implemented and are bearing fruit: the eurozone, Japan and, to some degree, those emerging markets which are seeing a recovery in their balance of payments.


Events to watch out for in H2 and beyond


Events to watch out for in H2 and beyond

*Lyxor CAR, July 2017.

Confident on commodities

The stronger global growth pulse could steel commodity prices, and finally tip the supply/demand balance in their favour. Should assets be less influenced by the dollar story and more by fundamentals, commodities - especially energy and industrial metals - stand to benefit from stronger economic growth in both developed and emerging markets.

OPEC attempts to curtail oil supply and therefore lift prices have to date been hampered by US shale production, but rig count should decline in H2 as weaker prices erode profitability. Wait for the right entry point. Copper prices, which have also been held back by oversupply, should climb as production capacity becomes more constrained.


Emerging into the light

The key external drivers for emerging markets – a tame Fed, a soft dollar and China – should linger for a while yet. Meanwhile, external vulnerabilities have receded, and growth prospects have improved. Be selective however, momentum is strong and valuations are already rich. Local monetary policies aren’t quite as supportive as they were. 


Advocating Asia

We still like Asia: valuations are not so stretched, earnings are recovering and liquidity conditions are supportive. We are however concerned about China’s financial stability, especially with the spectre of shadow banking rearing its ugly head again. Instead, we favour markets like Korea, where recovering earnings and fresh political leadership are set to revive the rally. Taiwan too is supported by better earnings prospects, foreign inflows and a turning in the electronics cycle. 

India also appeals, but lacklustre earnings growth could impede performance in the short term. In Japan, we favour small-caps because of their greater sensitivity to domestic economic improvements and their lesser sensitivity to movements in the yen.


Lift off in Europe...

Data seems to have turned in the eurozone. No longer is the region numbed by persistent pessimism; these days, investors are being wooed by rampant recovery. Growth is taking off, labour markets are mending and the credit cycle is expanding. All risk assets look attractive at this point, most obviously the sectors most closely linked to the recovery. We favour construction, consumer discretionary and banks. 

A caveat: inflation is still dormant. Regardless, the ECB can’t sit on its hands enjoying the sunny glow forever. Winter is coming – probably in the shape of €40bn per month fewer purchases throughout the first half 2018. Rate hikes look more distant. We’re idling in neutral on government bonds for now. Longer-term, we’re not confident on their outlook, but many have called the end of the bond bubble before us and we’re still waiting. Such is life.

...left out in the UK

Brexit negotiations are under way, and it’s already clear the path will be anything but smooth. We think people are being unduly complacent about the risks to growth. In our view, GDP growth will slow from 1.6% this year to 0.8% next. Inflation meanwhile should progress from 2.6% to 2.9% by year end 2018. This rise, and the acute uncertainty accompanying the Brexit talks, will hit consumption and weigh on activity. Although sterling has depreciated a lot already, we’re not sure the floor is in sight yet. 


Our key calls

United States

Commodities EM Japan

Eurozone UK


  • sU/W US Treasuries
  • Neutral S&P with defensive themes
  • O/W Growth vs. value O/W Minimum Variance
  • O/W Domestic vs. Global
  • U/W Small vs. Global
  • O/W HealthCare products & services
  • Neutral US High-yield for now. Lt negative
  • USD ST upside potential
  • Brent to end up in a $47-55 range
  • Tactical Buy Copper
  • Long Korea, Taiwan & India vs. China
  • Neutral EM debt: Prefer Argentina, Colombia, Indonesia
  • Neutral JP debt
  • Japan equities: prefer Topix small to Topix 100

  • Neutral on EMU Govies, turning negative
  • sO/W French OAT vs, German Bund
  • O/W Euro equity
  • sO/W Construction
  • sO/W Discretionary vs. Staples
  • Tactical Long Greece. LT sO/W defence
  • sO/W Banks
  • Neutral+ EU High-yield
  • Neutral GBP & Gilts
  • sO/W UK breakeven
  • sU/W UK FTSE 250
  • sO/W Ireland

  • sO/W Gold as a possible hedge

Key: U/W = underweight, O/W = overweight, s= soft, ST = short-term, LT = long-term

Source: Lyxor CAR, July 2017


All data sourced by: Lyxor & SG Cross Asset Research teams, July 2017. Opinions expressed are as at July 2017. 

This communication is for professional clients only.

This document is for the exclusive use of investors acting on their own account and categorised either as “Eligible Counterparties” or “Professional Clients” within the meaning of Markets In Financial Instruments Directive 2004/39/EC.

This document is of a commercial nature and not of a regulatory nature. This document does not constitute an offer, or an invitation to make an offer, from Société Générale, Lyxor International Asset Management or any of their respective affiliates or subsidiaries to purchase or sell the product referred to herein.

We recommend to investors who wish to obtain further information on their tax status that they seek assistance from their tax advisor. The attention of the investor is drawn to the fact that the net asset value stated in this document (as the case may be) cannot be used as a basis for subscriptions and/or redemptions. The market information displayed in this document is based on data at a given moment and may change from time to time. The figures relating to past performances refer or relate to past periods and are not a reliable indicator of future results. This also applies to historical market data. The potential return may be reduced by the effect of commissions, fees, taxes or other charges borne by the investor.

Lyxor International Asset Management (Lyxor ETF), société par actions simplifiée having its registered office at Tours Société Générale, 17 cours Valmy, 92800 Puteaux (France), 418 862 215 RCS Nanterre, is authorized and regulated by the Autorité des Marchés Financiers (AMF) under the UCITS Directive and the AIFM Directive (2011/31/EU). Lyxor ETF is represented in the UK by Lyxor Asset Management UK LLP, which is authorised and regulated by the Financial Conduct Authority in the UK under Registration Number 435658.

Connect with us on linkedin